日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials

替尔泽帕肽联合其他增重药物治疗对体重的影响:随机临床试验的事后分析

Galindo, Rodolfo J; Gudzune, Kimberly A; Look, Michelle; Lee, Clare J; Benabbad, Imane; Cao, Dachuang; Meng, Qier; Mojdami, Donna

One size does not fit all: Qualitative interviews with individuals with overweight or obesity and healthcare providers on navigating and supporting weight management

没有一种方法适用于所有人:对超重或肥胖人士和医疗保健提供者进行定性访谈,探讨如何指导和支持体重管理

Stanford, Fatima Cody; Mojdami, Donna; Edwards, Marie Louise; Desai, Urvi; Hasan, Anthony; Holub, Ashley; Qu, Alice; Mattera, Matthew; Ankerholz, Natalia; Sears, Ellen; Kirson, Noam; Shinde, Shraddha

Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT-1 study

替拉帕肽治疗肥胖成人患者体重减轻与生活质量之间的关联:SURMOUNT-1 研究结果

Gudzune, Kimberly A; Stefanski, Adam; Cao, Dachuang; Mojdami, Donna; Wang, Fangyu; Ahmad, Nadia; Ling Poon, Jiat

Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database

在非 2 型糖尿病患者中,替泽帕肽的真实世界使用情况和疗效:来自 Optum Market Clarity 数据库的结果

Hankosky, Emily R; Chinthammit, Chanadda; Meeks, Alexandra; Huang, Ahong; Ward, Jennifer M; Mojdami, Donna; Gibble, Theresa Hunter

Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1

接受替拉帕肽治疗的受试者在早期体重减轻反应方面随时间推移的体重减轻情况:SURMOUNT-1 研究的事后分析

Ard, Jamy; Lee, Clare J; Gudzune, Kimberly; Addison, Brandi; Lingvay, Ildiko; Cao, Dachuang; Mast, Casey J; Stefanski, Adam; Falcon, Beverly; Mojdami, Donna

Intentional Weight Loss and Associated Cancer Incidence Among People With Overweight or Obesity: A Systematic Literature Review

超重或肥胖人群主动减肥与相关癌症发病率:系统性文献综述

Liao, Chi-Yin; Schapiro, David; Mojdami, Donna; Sheffield, Kristin M; Hoog, Meredith M; Keni, Raghuvir; Gathirua-Mwangi, Wambui Grace; Kan, Hong

Early-Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials

早发性肥胖与替泽帕肽治疗:SURMOUNT临床试验的事后分析

Gourgari, Evgenia; Srivastava, Gitanjali; Kelly, Aaron S; Mojdami, Donna; Cao, Dachuang; Murphy, Madhumita A; Karanikas, Chrisanthi A; Lee, Clare J

Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program

根据生育阶段对接受替拉帕肽治疗的女性进行体重减轻情况分析:SURMOUNT 项目的一项事后分析

Tchang, Beverly G; Mihai, Andreea Ciudin; Stefanski, Adam; García-Pérez, Luis-Emilio; Mojdami, Donna; Jouravskaya, Irina; Gurbuz, Sirel; Taylor, Rebecca; Karanikas, Chrisanthi A; Dunn, Julia P

Modeling potential cost-effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity

对超重和肥胖患者,采用替泽帕肽与生活方式干预相比,进行潜在成本效益建模分析

Hoog, Meredith M; Kan, Hong; Deger, Kristen A; Sorensen, Sonja; Neff, Lisa M; Bae, Jay Patrick; Hankosky, Emily Ruth; Murphy, Madhumita; Mojdami, Donna; Houisse, Ivan; Harris, Mack S

Patient Experience of Treatment with Tirzepatide for Weight Management: Exit Interviews from SURMOUNT-4

SURMOUNT-4 研究中患者使用替泽帕肽进行体重管理的治疗体验:退出访谈

Carmichael, Chloe; Jouravskaya, Irina; Collins, Elizabeth; Burns, Danielle; Poon, Jiat Ling; Kitchen, Helen; Mojdami, Donna; Murphy, Madhumita; Ahmad, Nadia; Kanu, Chisom